Beijing Tong Ren Tang Chinese Medicine Co., Ltd. (BJTRF)
0.6484
0.00 (0.00%)
USD |
OTCM |
May 14, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 542.78M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 6.88% |
| Valuation | |
| PE Ratio | 10.65 |
| PE Ratio (Forward) | |
| PS Ratio | 2.796 |
| Price to Book Value | 1.702 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0510 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 56.77% |
Profile
| Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. It operates through the following geographical segments: Hong Kong, Mainland China and Overseas. The Hong Kong segment sells Chinese medicine and healthcare products and provides medical consultation and treatments through retail outlets, as well as wholesale in Hong Kong. The Mainland China segment engages in the wholesale of healthcare products in the Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside the Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments in other overseas countries/regions, including Macao. The company was founded in 1669 and is headquartered in Hong Kong. |
| URL | http://cm.tongrentang.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Jun. 16, 2026 |
| Last Ex-Dividend Date | Jun. 09, 2025 |
Profile
| Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. It operates through the following geographical segments: Hong Kong, Mainland China and Overseas. The Hong Kong segment sells Chinese medicine and healthcare products and provides medical consultation and treatments through retail outlets, as well as wholesale in Hong Kong. The Mainland China segment engages in the wholesale of healthcare products in the Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside the Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments in other overseas countries/regions, including Macao. The company was founded in 1669 and is headquartered in Hong Kong. |
| URL | http://cm.tongrentang.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Jun. 16, 2026 |
| Last Ex-Dividend Date | Jun. 09, 2025 |